Phase I study to assess safety and tolerability of investigative medication in pediatric patients with Sanfilippo syndrome (MPS IIIA)
A specialty healthcare company developing treatments for rare diseases sought Xperiome’s support for an early-stage pediatric trial program testing an investigational medicine in Sanfilippo syndrome. Xperiome was commissioned to run a nine-month online campaign to raise the profile of the program and to find and refer up to four of the nine patients needed for the Phase I study in the United States; to a study site that initially had no patients of their own.
We found, prescreened and referred three eligible children and their parents within three weeks of study start-up.
Download the Xperiome case study below
Sign up for updates
If you’re an industry professional and would like to subscribe to updates from our research team, including our research projects and our Rare Opinion blog, fill in your details below and we’ll add you to our mailing list.